International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.54% | -293.71% | -595.65% | 12.64% | 60.42% |
| Total Depreciation and Amortization | 6.19% | 1.01% | -5.83% | -9.86% | -11.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.06% | 18.15% | 27.94% | 30.17% | 29.32% |
| Change in Net Operating Assets | -26,866.67% | 59.83% | -85.65% | -1,583.33% | 98.68% |
| Cash from Operations | -98.60% | -70.72% | -93.90% | -8.93% | 179.82% |
| Capital Expenditure | -107.50% | -106.25% | -115.15% | -356.25% | -7,900.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.67% | -100.00% | 57.14% | 60.00% | 70.00% |
| Cash from Investing | -106.02% | -106.02% | -98.63% | -196.15% | -654.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.32% | -116.10% | -111.56% | -18.72% | 48.16% |